POCT testing hub

Point-of-care testing market analysis and insights

Technology improvements, a growing need to expand access to testing for diverse test settings and users, are driving a decentralisation trend in in-vitro diagnostics (IVD) point-of-care testing.

Clearstate offers point-of-care testing (POCT) and device market analysis, data, forecasts, and trend predictions to give you the insight to adjust your business strategy to the increasing demand for affordable point-of-care technology. Our POCT hub is regularly updated to share our findings on this fast-growing diagnostic alternative that is improving access to IVD testing.

Inquire now

What is point-of-care testing (POCT)?

Point-of-care testing (POCT), also known as near-patient testing (NPT), are tests performed outside the laboratory in different clinical settings – usually at the bedside or in wards utilising point-of-care testing devices. Point-of-care diagnostics can produce test results within minutes and are generally portable.

Explore the latest point-of-care diagnostics market insights

From point-of-care news to POCT market analysis, our articles provide concise and up-to-date information about the developments driving testing closer to patients. Explore the latest in the point-of-care devices market, technology and applications as affordable solutions are developed and adopted in the market. Uncover the challenges and opportunities countries face to increase diagnostic coverage, disease monitoring and patient outcomes for the population through POCT.

Learn from leading experts and analysts, and see real-world examples on how IVD testing is decentralising.

Point-of-care testing for infectious diseases

Clearstate’s global managing director, Ivy Teh, talks about the future of point-of-care testing (POCT) and other opportunities in the global market for testing of other infectious diseases.

Are there concerns with the supply chain for point-of-care testing reagents and controls in some parts of the world?

Clearstate’s global managing director, Ivy Teh, talks about the opportunities and challenges facing point-of-care testing, and some of the concerns around supply chain management.

What technology will revolutionise the point-of-care testing market?

Clearstate’s global managing director, Ivy Teh, talks about the importance of new technologies in the adoption of point-of-care testing.

Understand the point-of-care healthcare market

Discover more IVD insights or learn how our IVD Gateway solution or POCT Segment Trend Reports can help prepare your business for the future impact of the decentralisation trend in testing unfolding across countries, and key customer segments across a wide range of point-of-care applications.

A sample report by Clearstate

Unparalleled depth and actionable intelligence about China’s in-vitro diagnostics market

China has been aggressively implementing various policies to control healthcare costs. In recent years, volume-based procurement (VBP) has been one of the most impactful policies, significantly reshaping China’s IVD market landscape. How are policies expected to affect market demand and future growth across vital IVD segments — like centralised Dx, POC testing, molecular Dx and tissue Dx?

Learn more

A sample report by Clearstate

Unparalleled depth and actionable intelligence about Thailand’s in-vitro diagnostics market

The Centralised Diagnostics (CDx) market in Thailand experienced an overall growth of 10.7% from 2021 to 2022, as the market began its recovery from the COVID-19 pandemic, emerging as the leading contributor to the overall IVD market at the end of this period. But, what’s the outlook for the country’s diagnostic industry, and which segments should IVD companies focus on or avoid in the country?

Learn more

A sample report by Clearstate

Unparalleled depth and actionable intelligence about South Korea’s in-vitro diagnostics market

The IVD market in South Korea reached US$1.0 billion in 2022. Over the next five years, growth is expected to increase by 2.2% CAGR with an ageing population and increased healthcare expenditure.

Learn more

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.